H-Index
70
Scimago Lab
powered by Scopus
Clarivate
Analytics
Formerly the IP & Science
business of Thomson Reuters

Logo




eISSN: 1643-3750

Get your full text copy in PDF

Lupus erythematosus - continuing therapeutic problem

Anna WoŸzniacka, Anna Sysa-Jędrzejowska, Ewa Robak

Med Sci Monit 1997; 3(2): RA274-278

ID: 500739


Systemic lupus erythematosus (SLE) is a clasical example of an immune complex disease. Beacause there are not two patients who are identical, as regards the course of the disease the treatment should be individualized. SLE patients however, can be grouped by subsets, either throughout the course ot the disease or at certain episodes. Current treatment of SLE is mostly based on some form of generalized immune suppresion, antimalarials, steroids and non-steroid anti-inflamatory drugs, but some patients need new, sometimes experimental therapy. This article is a review of current knowledge about the SLE treatment.

This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree